Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. 'Let's do it' - Fortune
Quick Insights
The Bottom Line
President Trump is accelerating psychedelic review after Joe Rogan texted him about ibogaine.
How This Affects You
This could lead to expanded research or therapeutic access for psychedelic substances, potentially offering new treatment options for certain conditions.
AI Summary
President Trump is accelerating the review process for psychedelics after receiving a text message from Joe Rogan regarding ibogaine. This action follows Rogan's direct communication with the President, suggesting the potential benefits of the substance. The White House is now fast-tracking evaluations of these compounds, which could lead to expanded research or therapeutic access. This development highlights a direct influence on federal policy stemming from a personal communication between the President and a prominent media personality. The decision signals a potential shift in the administration's approach to psychedelic substances.
What's Being Done
The White House is fast-tracking evaluations of these compounds.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
Trump announces reforms to accelerate access to psychedelic drug treatments - The Guardian
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
This article is part of a story we're tracking:
Trump Administration's Push for Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and review processes for psychedelic-based therapies. This initiative, reportedly influenced by Joe Rogan, aims to loosen restrictions and explore the potential of psychedelics for mental health disorders.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelic Drug Review
President Donald Trump has signed an executive order to accelerate the review and research of psychedelic-based therapies for mental health disorders. This move, reportedly influenced by figures like Joe Rogan, aims to fast-track access to treatments like ibogaine and psilocybin.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelics Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, reportedly influenced by a text from podcaster Joe Rogan. This initiative aims to fast-track therapies like psilocybin and ibogaine.
Government Spending & Oversight
Tracking how taxpayer dollars are spent, where oversight gaps exist, and what watchdogs are uncovering. From federal budget battles and earmark controversies to inspector general reports and GAO audits, this deep dive follows the money trail through every level of government. We examine defense spending, entitlement programs, infrastructure investments, and the growing national debt — focusing on accountability, waste, and the policies that shape how America allocates its resources.
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
PoliticsTrump’s Rogan-inspired psychedelics order stokes cautious optimism
President Trump’s executive order loosening research restrictions on psychedelic medicine, which was kick-started by a text to Trump from podcaster Joe Rogan, could help legitimize an industry that’s long operated in the shadows. Advocates and researchers said they are optimistic about a potential shift in how the government views psychedelic drugs, but without further action,…
PoliticsTrump says UFO review uncovered 'interesting' documents - Reuters
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxPamVuTVFmekFOMkRRZTlTUi1vVFZ6MHZkelR3Rmxsd1dTUlRVek9IOGczVVJiQ2hKcmU0QjRfVmVTSFJDZmdoT1VSQUlIUTQ4cjVfNVlVbHY3QzBsRWY3aTZNWHNfVUQwSGxfVnp1M09PeVkwdE1YTEV5SlJwU0VQMkppZC1IVVk0Nmk3NmRXZFo5M0E0bDA3NFhZYw?oc=5" target="_blank">Trump says UFO review uncovered 'interesting' documents</a> <font color="#6f6f6f">Reuters</font>
HealthFDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
PoliticsScoop: Trump set to reclassify marijuana soon
<p>The <a href="https://www.axios.com/politics-policy/donald-trump" target="_blank">Trump</a> administration is expected to move to <a href="https://www.axios.com/2025/12/18/trump-reclassify-marijuana-weed-schedule-drugs" target="_blank">reclassify</a> marijuana as soon as Wednesday, per an administration official familiar with the matter.</p><p><strong>Why it matters: </strong>The move would make it easier to study medicinal applications of marijuana and could shore up support from <a href="https://www.axios.com/2026/04/20/trump-woos-rogan-after-split" target="_blank">influencers</a> who support the research.</p><hr><ul><li>The move follows an executive order from the president last year to reclassify marijuana as a Schedule III drug, which is a years-long process. </li></ul><p><strong>How it works: </strong><a href="https://www.axios.com/2025/12/12/trump-marijuana-federal-restrictions-reclassify" target="_blank">Reclassifying</a> marijuana eases U.S. Drug Enforcement Administratio...
PoliticsTrump Pardoned a Nursing Home Owner Who Owed Almost $19 Million to a Grieving Family
The post Trump Pardoned a Nursing Home Owner Who Owed Almost $19 Million to a Grieving Family appeared first on ProPublica .
PoliticsTrump’s pardons are costing shooting survivors millions
<p>A Trace analysis found that revenue from fining white-collar criminals is drying up – due to presidential pardons</p><p><em>This story was originally published by </em><em><a href="https://thetrace.org/">the Trace,</a> a non-profit newsroom covering gun violence in America. <a href="https://www.thetrace.org/newsletter">Sign up for its newsletters here.</a></em></p><p>Since his return to office last year, <a href="https://www.theguardian.com/us-news/donaldtrump">Donald Trump</a> has pardoned dozens of white-collar criminals. He’s also <a href="https://www.nbcnews.com/politics/trump-administration/trumps-pardons-forgive-financial-crimes-came-hundreds-millions-punishm-rcna248277">forgiven</a> their fines, penalties and restitution, to the tune of <a href="https://substack.com/@lizoyer/p-185209344">billions</a>. Some of that revenue was supposed to go to a fund to help victims of violent crime – and the organizations that serve them are feeling the pinch.</p> <a href="https://www.the...
US House Oversight members divided on Ghislaine Maxwell pardon, chairman says - Reuters
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxPNDg3cDdiN3ZXUzRqeXhxb015OVhyZmM2R1NudEktY2UxbVNVaWwxYkpfWnFfenBtc2Yyc1czcE5BcGhiU0lfbV9CRzhUY1ZDcFRRZmN6YjFNOWp3TDQxSGZ5eUdiRldWOEhoWE5LMko4U3lRZnI3UDBFMFp4LUZtNkEyX0c4aVBQVzdNUVMtNjZ6WUlVMVloVUQzUUpFTk9nVF9fc2JidXE0MFpSRGxKRGJmdUs3d0FIUExLSWtyWTg?oc=5" target="_blank">US House Oversight chair says some panel members open to Ghislaine Maxwell pardon</a> <font color="#6f6f6f">Reuters</font>
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
One in three Americans forced to make financial sacrifices for health coverage
Trump-branded data center project CEO departs
6 crew still missing after overturned ship that disappeared after typhoon is found near Saipan - AP News
A jury declared Live Nation a monopoly. But ticket prices won't drop just yet
